Background
Chang Xing was born in 1952, China.
幸 常
Chang Xing was born in 1952, China.
Graduated from the Beijing University of Iron and Steel Technology, Chang joined the Chinese Communist Party in September 1976, and in 1993 he enrolled in the graduate program of the Central Party School, majoring in world economy.
Since 1984, he has held various titles in the Chengde municipal government including deputy director (April 1984 to May 1986), deputy secretary-general and director of economic research (May 1986 to April 1990), and deputy mayor (April 1990 to June 2001). In 2001, Chang was named the deputy director of the Hebei Economic and Trade Commission, a position he held for two years. This role led to Chang’s involvement with the North China Pharmaceutical Co., Ltd, and in 2003 he was named board chairman and party secretary of NCPC.
Under China’s planned economy, NCPC was one of the key construction projects of the First Five-Year Plan that began in 1953. After five years of construction, the factory was put into operation in 1958. Being one of the world’s leading producers of antibiotics, both in terms of technology and scale of production at that time, NCPC contributed signifi- cantly to the commercial production of antibiotics in China. Over 50 years NCPC has been continually growing and taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranking as one of the top 500 enterprises and the best profit-makers in China. In 2002, NCPC achieved domestic sales revenue of US$700million and export sales of US$100 million. With 18 500 employees, its total assets reached US$2 billion.
Chang believed that only through innovation could a company sustain continuous development. For maximum gain, technology should combine organically with the concept and system of innovation; and for long-term achievement, internal and external resources should integrate efficiently. Under his leadership, the North China Pharmaceutical Co., Ltd has made major progress and received numerous awards, including recognition as one of the top 500 Chinese companies, an enterprise honor for quality and efficiency, recognition as one of the national enterprises with the greatest customer satisfaction, and as one of the top three exporting companies in Western medi- cine. In 2004, Forbes recognized NCPC as one of the most valuable industrial brands in China; the company was also named as a national enterprise with excellence in quality management, and ranked among the top ten most competitive public enterprises in the fast-growing Chinese pharmaceutical industry.